Resource impact statement

No significant resource impact is anticipated

We do not expect this guidance to have a significant impact on resources; that is, it will be less than £5 million per year in England (or £9,100 per 100,000 population).

This is because the technology is a further treatment option and is available at a similar price to alternatives.

This technology is commissioned by clinical commissioning groups. Providers are NHS hospital trusts and primary care GP practices.


This page was last updated: